AR, apoE, and cognitive functionby: Jacob Raber
Hormones and Behavior, Vol. 53, No. 5. (May 2008), pp. 706-715.
|
Reviews
[Write a review of this article]
There are no reviews of this article
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
AbstractReduced androgen levels in aged men and women might be risk factors for age-related cognitive decline and Alzheimer's disease (AD). Ongoing clinical trials are designed to evaluate the potential benefit of estrogen in women and of testosterone in men. In this review, we discuss the potential beneficial effects of androgens and androgen receptors (ARs) in males and females. In addition, we discuss the hypothesis that AR interacts with apolipoprotein (apoE)4, encoded by [epsilon]4 and a risk factor for age-related cognitive decline and AD, and the potential consequences of this interaction.
BibTeX record
RIS record